(Es)ketamine in functional neurological disorder: a systematic review
Frontiers in Psychiatry · 20.07.2026 · 17
DOI: 10.3389/fpsyt.2026.1872389 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 20.07.2026. Verfasst von Bruce Tamilson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychiatry Service, South West London & St George's Mental Health NHS Trust, St George's Hospital, London, United Kingdom. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Background and aim Functional neurological disorder (FND) is a common and disabling condition for which effective treatments remain limited. Clinical outcomes are often variable, particularly in chronic and comorbid presentations. Ketamine and esketamine are increasingly used across a range of neuropsychiatric conditions. This review aimed to synthesise the existing evidence regarding their use in FND.
Methods
A systematic review of PubMed, PsycINFO and Google Scholar was conducted up to December 2025. Studies reporting clinical outcomes following (Es)ketamine administration in functional neurological symptoms were included. Owing to substantial clinical and methodological heterogeneity, findings were synthesised narratively.
Results
Thirteen studies were identified, predominantly comprising case reports and small case series. Across the included studies, some patients were reported to experience improvement in functional motor symptoms, functional dissociative seizures, and other functional presentations following ketamine or esketamine administration. Interpretation of these findings is limited by the uncontrolled nature of the evidence base, heterogeneity of diagnoses and outcomes, and the potential influence of publication and expectancy bias. Adverse effects were variably reported and were generally described as transient in supervised clinical settings.
Conclusion
The current evidence base is limited to predominantly uncontrolled and highly heterogeneous studies and is insufficient to establish the efficacy of (Es)ketamine for FND. Although improvements in functional symptoms have been reported across several FND presentations, it remains unclear whether these reflect direct effects on functional symptoms, indirect benefits arising from psychiatric improvement, or other non-specific therapeutic factors. While no firm conclusions regarding efficacy can be drawn, the existing data suggest that further investigation is justified, and prospective controlled trials are needed to clarify the potential role of (Es)ketamine in FND.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuropsychiatry Service, South West London & St George's Mental Health NHS Trust, St George's Hospital, London, United Kingdom.
- Department of Neuroscience, St George's University of London, London, United Kingdom.
- Division of Psychiatry, University College of London, London, United Kingdom.
- Department of Liaison Psychiatry, Kingston Hospital, London, United Kingdom.
- Atkinson Morley Regional Neurosciences Centre, St George's University Hospital, London, United Kingdom.
- Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
Förderung
- Wellcome Trust
Zitieren
APA
Tamilson, B., Chitolie, M., Coebergh, J., Agrawal, N., Poole, N., Butler, M., Kanaan, R., & Nicholson, T. (2026). (Es)ketamine in functional neurological disorder: a systematic review. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1872389
Vancouver
Tamilson B, Chitolie M, Coebergh J, Agrawal N, Poole N, Butler M, et al. (Es)ketamine in functional neurological disorder: a systematic review. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1872389
BibTeX
@article{Tamilson2026,
author = {Tamilson, Bruce and Chitolie, Michael and Coebergh, Jan and Agrawal, Niruj and Poole, Norman and Butler, Matt and Kanaan, Richard and Nicholson, Timothy},
title = {(Es)ketamine in functional neurological disorder: a systematic review},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1872389}
}
EUVIMED